CHEO Telethon raises $7.1 million

The Children's Hospital of Eastern Ontario has seven million reasons to thank you!

The 31st annual CHEO telethon raised $7,121,350!

President and CEO of the CHEO foundation, Kevin Keohane says the telethon is extremely important.

"We are a little different in that we cannot target our patient population for fundraising," Keohane tells CFRA. "So we absolutely have to rely on the rest of the community to come in and support kids and young families."

This weekend's telethon, which aired on CTV, featured stories from the local Superheroes - doctors and nurses who tirelessly give their all to help the patients at the Children's Hospital of Eastern Ontario, and the children and their families who inspire them.

These are just some of their stories:

Ben Delaney was 12 years old when he was diagnosed with cancer. He ended up losing a leg to the illness.

Now, he's 17 and a Paralympic Bronze medalist.

He played for Canada's sledge hockey team in Sochi.

He'll have his last oncology appointment at CHEO this Thursday.

"My final one is going to be a bummer, I really like CHEO," Ben said. "Everyone's just super nice. I'm going to miss a lot of the people. It's just such a good, positive environment."

Ben says the doctors and nurses at CHEO played a major role in his feeling positive and comfortable during treatment.

He says that's why being involved in the Telethon this year was important for him.

Christine and Alan Latter say their involvement at the Telethon is their way of saying Thank you.

Their 12-year-old daughter Anne Marie has had cystic fibrosis since she was born, and was recently diagnosed with diabetes.

Alan says CHEO is a home away from home for Anne Marie when she's not doing well.

"For us it's even more important because Anne Marie has needed CHEO since the day she was born," he says. "And she'll continue to need CHEO's services until the day she's an adult."

Anne Marie says it's important to her to help the resources at CHEO develop further.

Leave a comment:

· Subscribe to comments
Be the first to comment here!